scispace - formally typeset
Open AccessJournal ArticleDOI

Recent advances in the molecular pathophysiology of atrial fibrillation

Reads0
Chats0
TLDR
The ways in which cardiac disease states, extracardiac factors, and abnormal genetic control lead to the arrhythmia are discussed, including the potential therapeutic implications that might arise from an improved mechanistic understanding.
Abstract
Atrial fibrillation (AF) is an extremely common cardiac rhythm disorder that causes substantial morbidity and contributes to mortality. The mechanisms underlying AF are complex, involving both increased spontaneous ectopic firing of atrial cells and impulse reentry through atrial tissue. Over the past ten years, there has been enormous progress in understanding the underlying molecular pathobiology. This article reviews the basic mechanisms and molecular processes causing AF. We discuss the ways in which cardiac disease states, extracardiac factors, and abnormal genetic control lead to the arrhythmia. We conclude with a discussion of the potential therapeutic implications that might arise from an improved mechanistic understanding.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Isolation of human atrial myocytes for simultaneous measurements of Ca2+ transients and membrane currents.

TL;DR: A method for isolation of human atrial myocytes which is suitable for both patch-clamp studies and simultaneous measurements of intracellular Ca(2+) concentrations is described.
Journal ArticleDOI

Incidence and predictors of atrial fibrillation and its impact on long-term survival in patients with supraventricular arrhythmias

TL;DR: The incidence of AF is high in patients with other forms of SVA, and the most common association is between AFL and AF, although AF did not emerge as an independent predictor of mortality when adjusted for other covariates.
Journal ArticleDOI

Antihyperglycemic drugs use and new-onset atrial fibrillation in elderly patients.

TL;DR: This study investigated the association between different classes of antihyperglycemic drugs and NAF in elderly patients and found no clear link between these classes and new‐onset atrial fibrillation.
Journal ArticleDOI

Atrial Cardiomyopathy: Pathophysiology and Clinical Consequences.

TL;DR: In this paper, the authors summarize the underlying pathophysiology and remodeling processes observed in the development of an atrial cardiomyopathy, thrombogenesis, and atrial fibrillation.
Journal ArticleDOI

Scar-based catheter ablation for persistent atrial fibrillation.

TL;DR: The role of atrial scar/fibrosis in the pathophysiology ofatrial fibrillation is outlined and how this encouraged clinical studies assessing the atrial substrate using scar-based mapping, which highlighted the need for a better understanding of the substrate and mechanisms of arrhythmia maintenance in this population.
References
More filters
Journal ArticleDOI

Spontaneous Initiation of Atrial Fibrillation by Ectopic Beats Originating in the Pulmonary Veins

TL;DR: The pulmonary veins are an important source of ectopic beats, initiating frequent paroxysms of atrial fibrillation and these foci respond to treatment with radio-frequency ablation.
Journal ArticleDOI

Atrial Fibrillation Begets Atrial Fibrillation A Study in Awake Chronically Instrumented Goats

TL;DR: Artificial maintenance of AF leads to a marked shortening of AERP, a reversion of its physiological rate adaptation, and an increase in rate, inducibility and stability of AF.
Journal ArticleDOI

Secular Trends in Incidence of Atrial Fibrillation in Olmsted County, Minnesota, 1980 to 2000, and Implications on the Projections for Future Prevalence

TL;DR: The age-adjusted incidence of AF increased significantly in Olmsted County during 1980 to 2000 and the projected number of persons with AF for the United States will exceed 10 million by 2050, underscoring the urgent need for primary prevention strategies against AF development.
Journal ArticleDOI

Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis

TL;DR: It is concluded that miR-29 acts as a regulator of cardiac fibrosis and represents a potential therapeutic target for tissue fibrosis in general.
Related Papers (5)